Ficha del valor · trimestre archivado
PRME
Prime Medicine, Inc. · Healthcare · Biotechnology
18Tenedores rastreados
+3Δ titulares
30.74MAcciones mantenidas
$170.29MValor declarado
+3Nuevas posiciones
−0Cierres
Señales de momentum (gestores comparables):
amplitud de titulares +20.0% ·
flujo de acciones +30.0% ·
nuevas posiciones netas +16.7%
— fórmula
Acumulación amplia — aumento de acciones entre más titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q3 2025
Participación a lo largo del tiempo
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 78 | +1 | 62.51M | $230.64M | +6 | −5 |
| Q1 2026 | 80 | +2 | 55.31M | $192.04M | +9 | −7 |
| Q4 2025 | 78 | 0 | 56.37M | $195.61M | +1 | −1 |
| Q3 2025 | 18 | +3 | 30.74M | $170.29M | +3 | — |
| Q2 2025 | 12 | +1 | 18.57M | $45.87M | +1 | — |
| Q1 2025 | 8 | 0 | 10.06M | $20.03M | +1 | −1 |
| Q4 2024 | 8 | -1 | 11.48M | $33.53M | +2 | −3 |
| Q3 2024 | 8 | -1 | 11.29M | $43.71M | +1 | −2 |
| Q2 2024 | 9 | — | 11.11M | $57.12M | — | — |
Quién lo tiene en cartera · Q3 2025
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (pasivo) | 5.65M | +26.0% | $31.31M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | BlackRock ✦ (pasivo) | 5.65M | +26.0% | $31.31M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | BlackRock ✦ (pasivo) | 5.65M | +26.0% | $31.31M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | BlackRock ✦ (pasivo) | 5.65M | +26.0% | $31.31M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | BlackRock ✦ (pasivo) | 5.65M | +26.0% | $31.31M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | BlackRock ✦ (pasivo) | 5.65M | +26.0% | $31.31M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | BlackRock ✦ (pasivo) | 5.65M | +26.0% | $31.31M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | BlackRock ✦ (pasivo) | 5.65M | +26.0% | $31.31M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | ARK Investment Management ✦ | 5.48M | +135.8% | $30.35M | 0.2% | ▲ Add | 6 | SEC ↗ |
| 10 | The Vanguard Group ✦ (pasivo) | 4.92M | +35.7% | $27.27M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | The Vanguard Group ✦ (pasivo) | 4.92M | +35.7% | $27.27M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | The Vanguard Group ✦ (pasivo) | 4.92M | +35.7% | $27.27M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | Fidelity (FMR) ✦ | 2.81M | -24.9% | $15.58M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | Fidelity (FMR) ✦ | 2.81M | -24.9% | $15.58M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 15 | Fidelity (FMR) ✦ | 2.81M | -24.9% | $15.58M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | D. E. Shaw & Co. ✦ | 2.22M | Nuevo | $12.28M | 0.0% | New | 1 | SEC ↗ |
| 17 | Geode Capital Management ✦ (pasivo) | 1.77M | +16.9% | $9.79M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 18 | Geode Capital Management ✦ (pasivo) | 1.77M | +16.9% | $9.79M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 19 | Millennium Management ✦ | 1.42M | +858.5% | $7.86M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 20 | State Street Global Advisors ✦ (pasivo) | 1.30M | +4.6% | $7.18M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 21 | Renaissance Technologies ✦ | 1.13M | +407.9% | $6.29M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 22 | Citadel Advisors ✦ | 900.14K | +72.6% | $4.99M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 23 | Citadel Advisors ✦ | 900.14K | +72.6% | $4.99M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 24 | Adage Capital Partners ✦ | 771.36K | Nuevo | $4.27M | 0.0% | New | 1 | SEC ↗ |
| 25 | Morgan Stanley ✦ | 731.00K | — | $4.05M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | Morgan Stanley ✦ | 731.00K | — | $4.05M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | Morgan Stanley ✦ | 731.00K | — | $4.05M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Morgan Stanley ✦ | 731.00K | — | $4.05M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | Morgan Stanley ✦ | 731.00K | — | $4.05M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | Morgan Stanley ✦ | 731.00K | — | $4.05M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | Two Sigma Investments ✦ | 447.67K | +73.2% | $2.48M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 32 | AQR Capital Management ✦ | 414.21K | -2.4% | $2.29M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 33 | AQR Capital Management ✦ | 414.21K | -2.4% | $2.29M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 34 | AQR Capital Management ✦ | 414.21K | -2.4% | $2.29M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 35 | AQR Capital Management ✦ | 414.21K | -2.4% | $2.29M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 36 | Goldman Sachs Group ✦ | 410.74K | — | $2.28M | 0.0% | n/c | 1 | SEC ↗ |
| 37 | Goldman Sachs Group ✦ | 410.74K | — | $2.28M | 0.0% | n/c | 1 | SEC ↗ |
| 38 | Wellington Management ✦ | 205.32K | Nuevo | $1.14M | 0.0% | New | 1 | SEC ↗ |
| 39 | Wellington Management ✦ | 205.32K | Nuevo | $1.14M | 0.0% | New | 1 | SEC ↗ |
| 40 | Wellington Management ✦ | 205.32K | Nuevo | $1.14M | 0.0% | New | 1 | SEC ↗ |
| 41 | JPMorgan Chase ✦ | 86.78K | — | $480,750 | 0.0% | n/c | 1 | SEC ↗ |
| 42 | JPMorgan Chase ✦ | 86.78K | — | $480,750 | 0.0% | n/c | 1 | SEC ↗ |
| 43 | JPMorgan Chase ✦ | 86.78K | — | $480,750 | 0.0% | n/c | 1 | SEC ↗ |
| 44 | JPMorgan Chase ✦ | 86.78K | — | $480,750 | 0.0% | n/c | 1 | SEC ↗ |
| 45 | T. Rowe Price ✦ | 74.50K | +14.1% | $413,000 | 0.0% | ▲ Add | 6 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| D. E. Shaw & Co. | $12.28M | 0.0% |
| Adage Capital Partners | $4.27M | 0.0% |
| Wellington Management | $1.14M | 0.0% |
| Wellington Management | $1.14M | 0.0% |
| Wellington Management | $1.14M | 0.0% |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 189 tenedores, 97.53M acciones, $314.58M declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Frecuentemente cotituladas
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.
Procedencia: Participación a partir de posiciones en acciones ordinarias de 13F procesadas (universo rastreado, conjuntos comparables para cambios); filas de iniciados de los Formularios 3/4/5; participaciones de los Schedules 13D/13G; cada filing enlaza con su original en SEC EDGAR.
Período de reporte: Q3 2025 ·
Metodología ·
Obtener esto a través de la API